HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Npc169089

HCID 65243
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
15291-77-7
Standard SMILES
CC1C(=O)OC2C(O)C34C5CC(C(C)(C)C)C36C(OC(=O)C6O)OC4(C(=O)O5)C12O
InChIKey
SQOJOAFXDQDRGF-UHFFFAOYSA-N
Molecular formula
C20H24O10
Average molar mass
424.4 g/mol
Monoisotopic mass
424.13694696

Overview

Ginkgolide B has been reported in Ginkgo and Ginkgo biloba with data available.

Names & identifiers

Preferred name
Npc169089
IUPAC
8-tert-butyl-6,12,17-trihydroxy-16-methyl-2,4,14,19-tetraoxahexacyclo[8.7.2.01,11.03,7.07,11.013,17]nonadecane-5,15,18-trione
English name
Ginkgolide B
Molecular formula
C20H24O10
Molecular weight
424.4

Names & synonyms

RefChem:1092769Npc169089Gingko lactoneGinkgolideBSR-01000597598bn52021Ginklide BGink;lide BCHEMBL266625ginkgolide B from ginkgo leavesorb1305072orb3140886
Show more names
BN 52021BGinkgolidGINKGOLIDE BGINKGOLIDE B(SH)7-DEOXYGINKGOLIDE CGINKOLIDE BBN 52021Ginkgolide B (BN-52021)Ginkgolide B (Standard)Ginkgolide B, 10 mM in DMSOGinkgolideA,1-hydroxy-, (1β)-
SCHEMBL142799031-Hydroxy-(1beta)-Ginkgolide ASQOJOAFXDQDRGF-UHFFFAOYSA-NMSK10397NSC110257PDSP1_000734PDSP2_000724AKOS015895882

Database identifiers

CAS
15291-77-7
PubChem CID
65243
ChEMBL
CHEMBL266625

Properties

Computed structural properties

XLogP
-0.4
Topological polar surface area
149 Ų
Hydrogen bond donors
3
Hydrogen bond acceptors
10
Rotatable bonds
1
Heavy atoms
30
Formal charge
0
Complexity
925

Experimental & physicochemical properties

LogP0.59
Melting Point280 °C
Physical DescriptionSolid

Physicochemical properties

Melting point
280 °C · 280°C (dec.)
alpha
24 · D24 -52.6° (c = 1 in ethanol)
Boiling point
762.4 · 762.4±60.0 °C(Predicted)
Density
1 · 1+-.0.1 g/cm3(Predicted)
storage temp.
-20 °C · Sealed in dry,Store in freezer, under -20°C
solubility
Soluble in DMSO (up to 40 mg/ml) or in Ethanol (up to 10 mg/ml).
form
Solid
pka
1 · pKa1 7.14; pKa2 8.60; pKa3 11.89(at 25℃)
color
White
Water Solubility
Soluble in DMSO. Slightly soluble in water and ethanol

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

F
10-21
wgk
3
hs_code
29322090
Signal word
Warning
Symbol(GHS)
GHS07
safety_code
24/25
Hazard statements
H319-H315-H335
Precautionary statements
P264-P280-P302+P352-P321-P332+P313-P362-P264-P280-P305+P351+P338-P337+P313P

Chemistry & industry

Pharmacology

Cellular LocationsCytoplasm
Applications · 4 items

DescriptionGinkgolide B is an important active ingredient derived from the leaf extract of Ginkgo biloba (Ginkgo biloba leaf extract, GBLPE), a member of the Ginkgoaceae family. It belongs to the class of terpenoid ketones and is a diterpene trilactone containing six five-membered rings in its molecular structure. The molecule comprises a spiro[4.4]nonane skeleton and a tetrahydrofuran ring, and is readily soluble in solvents such as ethyl acetate, methanol, ethanol, and dimethyl sulfoxide.

HistoryThe leaf of Ginkgo biloba is sweet, bitter, astringent, and mild. With activating blood circulation to remove blood stasis, dredging collaterals, relieving pain, and asthma, it is applied for treating blood stasis, chest pain, stroke, lung deficiency cough, and hyperlipidemia.As early as in the 1930s, scientists began to study ginkgo and harvest a variety of ginkgolide . Ginkgolide B was isolated and its structure illustrated by Wan Shan etal. in 1967. Subsequently, it was synthesized by Corey etal. in 1988. The preparation of effective components of Ginkgo biloba has been listed at home and abroad with development.The Ginkgo biloba extract consisting of ticlopidine is widely used in overseas market for the treatment of cerebral infarction. Intravenous injection of ginkgolide B is applied for the treatment of inflammation, but the project has been in the state, and there is no progress in it for many years. In addition, whether other extract of Ginkgo biloba can be used for the treatment of stable angina, cognitive impairment is still in preclinical research status.

UsesFamily of bioactive terpenes treating cardiovascular and cerebrovascular diseases. Specific platelet activating factor (PAF) antagonists

UsesGinkgolide B is used as a potent PAF-R antagonist. Ginkgolide B speeds up PAF hydrolysis by promoting PAF-AH I α2 homodimer activity. Additionally, this compound has been reported to inhibit neutrophil degranulation in vitro. Inhibits superoxide production in vitro and inhibits bronchoconstriction and is neuroprotective following oral administration in vivo.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
BRN
4727611 · 4727611
Stability
2 years · Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 3 months
InChIKey
SQOJOAFXDQDRGF-MMQTXUMRSA-N
SMILES
[C@@]12(O)[C@]34C(=O)O[C@@H]5C[C@@H](C(C)(C)C)C6([C@@H](O)C(=O)O[C@@]6([H])O3)C45[C@H](O)[C@]1([H])OC(=O)[C@H]2C
LogP
2.07 · 2.070 (est)
CAS DataBase Reference
15291 · 15291-77-7(CAS DataBase Reference)
FDA UNII
149 B9460 · DF149B9460
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
319 · H319-H315-H335
Precautionary statements
264 · P264-P280-P302+P352-P321-P332+P313-P362-P264-P280-P305+P351+P338-P337+P313P
Safety Statements
24 · 24/25
WGK Germany
3 · 3
F
10 · 10-21
HS Code
29322090 · 29322090

Upstream & downstream products

Upstream raw materials

Ginkgolide C